Stancer HC, Reed KL.
Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum.
Am J Psychiatry. 1986 Dec;143(12):1597-600.

Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E.
The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
Clin Pharmacol Ther. 1984 Sep;36(3):343-9.

Reed K, McKim HR.
ECG changes in pure impramine overdose as function of plasma level.
Can Psychiatr Assoc J. 1978 Dec;23(8):573-7.

Reed K, Smith RC, Schoolar JC, Hu R, Leelavathi DE, Mann E, Lippman L.
Cardiovascular effects of nortriptyline in geriatric patients.
Am J Psychiatry. 1980 Aug;137(8):986-9.

Smith RC, Reed K, Leelavathi DE.
Pharmacokinetics and the effects of nortriptyline in geriatric depressed patients.
Psychopharmacol Bull. 1980 Jul;16(3):54-7.

Kumar V, Smith RC, Reed K, Leelavathi DE.
Plasma levels and effects of nortriptyline in geriatric depressed patients.
Acta Psychiatr Scand. 1987 Jan;75(1):20-8.

Watson CP, Vernich L, Chipman M, Reed K.
Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial.
Neurology. 1998 Oct;51(4):1166-71.

Watson CP, Chipman M, Reed K, Evans RJ, Birkett N.
Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial.
Pain. 1992 Jan;48(1):29-36.

Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J.
Amitriptyline versus placebo in postherpetic neuralgia.
Neurology. 1982 Jun;32(6):671-3.

Dorian P, Sellers EM, Reed KL, Warsh JJ, Hamilton C, Kaplan HL, Fan T.
Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction.
Eur J Clin Pharmacol. 1983;25(3):325-31.

Dorian P, Sellers EM, Reed KL.
Spurious detection of a high serum imipramine level due to coating of Vacutainer stopper.
Can Med Assoc J. 1982 Sep 15;127(6):509-10.

Hrdina PD, Hutchinson LJ, Lapierre YD, Perel JM, Reed KL.
Pharmacokinetics of psychotropic drugs: what can it tell us?
Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):681-8.

Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E.
The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
Clin Pharmacol Ther. 1984 Sep;36(3):343-9.

Dorian P, Sellers EM, Reed KL, Warsh JJ, Hamilton C, Kaplan HL, Fan T.
Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction.
Eur J Clin Pharmacol. 1983;25(3):325-31.

Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J.
Amitriptyline versus placebo in postherpetic neuralgia.
Neurology. 1982 Jun;32(6):671-3.

Clothier J, Kelley JT, Reed K, Reilly EL.
Varying rates of alcohol metabolism in relation to detoxification medication.
Alcohol. 1985 May-Jun;2(3):443-5.

Clothier J, Reed K.
Targeting therapeutic plasma levels of nortriptyline from test dose plasma concentrations.
J Clin Psychopharmacol. 1984 Aug;4(4):216-7.

Kutcher SP, Shulman KI, Reed K.
Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study.
Can J Psychiatry. 1986 Nov;31(8):752-4.

Stancer HC, Reed KL.
Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum.
Am J Psychiatry. 1986 Dec;143(12):1597-600.

Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E.
The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
Clin Pharmacol Ther. 1984 Sep;36(3):343-9.

Kumar V, Smith RC, Reed K, Leelavathi DE.
Plasma levels and effects of nortriptyline in geriatric depressed patients.
Acta Psychiatr Scand. 1987 Jan;75(1):20-8.

Tugg LA, Desai D, Prendergast P, Remington G, Reed K, Zipursky RB.
Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
Schizophr Res. 1997 May 3;25(1):71-8.

Kapur S, Zipursky R, Roy P, Jones C, Remington G, Reed K, Houle S.
The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study.
Psychopharmacology (Berl). 1997 May;131(2):148-52.

Remington G, Pollock B, Voineskos G, Reed K, Coulter K.
Acutely psychotic patients receiving high-dose haloperidol therapy.
J Clin Psychopharmacol. 1993 Feb;13(1):41-5.

Remington GJ, Voineskos G, Pollock B, Reed K, Coulter K.
Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
Am J Psychiatry. 1990 Sep;147(9):1231-3.

Kennedy SH, de Groot J, Ralevski E, Reed K.
A comparison of adinazolam and desipramine in the treatment of major depression.
Int Clin Psychopharmacol. 1991 Summer;6(2):65-76.

Watson CP, Vernich L, Chipman M, Reed K.
Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial.
Neurology. 1998 Oct;51(4):1166-71.

Watson CP, Chipman M, Reed K, Evans RJ, Birkett N.
Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial.
Pain. 1992 Jan;48(1):29-36.

Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J.
Amitriptyline versus placebo in postherpetic neuralgia.
Neurology. 1982 Jun;32(6):671-3.

Ozdemir V, Tyndale RF, Reed K, Herrmann N, Sellers EM, Kalow W, Naranjo CA.
Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers.
J Clin Psychopharmacol. 1999 Oct;19(5):472-5.

Ozdemir V, Naranjo CA, Shulman RW, Herrmann N, Sellers EM, Reed K, Kalow W.
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
J Clin Psychopharmacol. 1998 Jun;18(3):198-207.

Ozdemir V, Naranjo CA, Herrmann N, Shulman RW, Sellers EM, Reed K, Kalow W.
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.
J Clin Psychopharmacol. 1998 Feb;18(1):55-61.

Ozdemir V, Naranjo CA, Herrmann N, Reed K, Sellers EM, Kalow W.
Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo.
Clin Pharmacol Ther. 1997 Sep;62(3):334-47.